IP Library Granted Patent US 9,675,580
Granted Patent B2
US 9,675,580 · App. 15/058,065 · Granted Jun 13, 2017

Method of treatment for enhancing exercise performance

Inventors: Kyong-Tai Kim (Pohang-si, KR); Bo-Hwa Choi (Pohang-si, KR); Hoe-Yune Jung (Gyeongju-si, KR); Jae-Cheon Shin (Gyeongju-si, KR); Sang-Taek Oh (Pohang-si, KR); Myung-Su Kang (Pohang-si, KR)
Assignee: Kyong-Tai Kim
A61K31/352A23L33/105A61K9/0053A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,675,580
App. No.
15/058,065
Granted
Jun 13, 2017
Kind
B2
Abstract

Provided is a composition containing myricetin or a pharmaceutically available salt thereof as an active ingredient. The composition increases exercise capacity and enhances physical strength. In addition, the composition prevents aging and recovers from fatigue. The composition increases energy efficiency by improving the function of mitochondria, and also has an antiobesity effect by increasing energy consumption. Therefore, the composition may be significantly applied in a functional food or medicine field.

Claims (7)

1. A method of treatment for enhancing exercise capacity, the method comprising:

orally administering, to a subject in need of such treatment, an effective amount of myricetin or a pharmaceutically acceptable salt thereof; and

subsequently estimating expression by PCR of a peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1 α), nuclear respiratory factor-1 (NRF-1), or peroxisome proliferator-activated receptor-δ (PPAR-δ) gene or sirtuin-1 (SIRT-1) gene.

2. The method of claim 1 , wherein the oral administration is repeated for an extended period.

3. The method of claim 2 , wherein the extended period is at least 2 weeks.

4. The method of claim 2 , wherein the effective amount per day is from 0.01 to 100 mg for 1 kg of the subject's weight.

5. The method of claim 2 , wherein the effective amount per day is 50 mg for 1 kg of the subject's weight.

Assignments (3)
MERGER Recorded Apr 15, 2022
From: NOVMETAHEALTH CO., LTD.
To: NOVMETAPHARMA CO., LTD.
Reel/Frame 059720/0697 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2019
From: KIM, KYONG-TAI
To: NOVMETAHEALTH CO., LTD.
Reel/Frame 048622/0758 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2017
From: BIOKOGEN CO., LTD.
To: KIM, KYONG-TAI
Reel/Frame 042169/0692 →
Priority Claims (1)
KR 10-2012-0113176 · Oct 11, 2012 · national
Continuity (2)
Division 14435424
Related Publication 20160175277A1 · Jun 23, 2016